Concepedia

Publication | Open Access

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma

24

Citations

27

References

2020

Year

Abstract

In summary, our study showed that AHNAK2 might be a novel biomarker in LUAD and revealed the potential mechanism of AHNAK2 in LUAD progression which could provide new insights for target therapy.

References

YearCitations

Page 1